Article Details

Roche in licensing deal with KaliVir to develop oncolytic virus candidates for cancer | Seeking Alpha

Retrieved on: 2022-05-23 20:39:34

Tags for this article:

Click the tags to see associated articles and topics

Roche in licensing deal with KaliVir to develop oncolytic virus candidates for cancer | Seeking Alpha. View article details on hiswai:

Excerpt

Roche (RHHBY) has brokered a licensing deal with privately held KaliVir Immunotherapeutics for the development of oncolytic virus candidates that ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up